Skip to Content

PT Kalbe Farma Tbk ADR PTKFY Stock Quote

| Rating as of

Morningstar‘s Stock Analysis PTKFY

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics PTKFY

Company Profile PTKFY

Business Description

Kalbe Farma is a drug manufacturing company that focuses on prescription pharmaceuticals, over-the-counter drugs, energy drinks, and nutrition products. The company operates four segments: prescription pharmaceuticals, consumer health, Nutritionals, and distribution and logistics. Most of the company's gross profits are derived from the Nutritionals and prescription pharmaceuticals segments. The company primarily operates in Indonesia but has operations across various ASEAN countries, Nigeria, and South Africa.

Jalan Let. Jend. Suprapto Kav. 4, Gedung KALBE, Cempaka Putih
Jakarta, 10510, Indonesia
T +62 2142873888
Industry Drug Manufacturers - General
Most Recent Earnings Jun 30, 2022
Fiscal Year End Dec 31, 2022
Stock Type
Employees 12,501